Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets

Approval Number

国药准字H20243637

Company山东京卫制药有限公司

Registration Date

April 30, 2024

Drug Information

Generic Name

盐酸帕罗西汀肠溶缓释片

Dosage Form

缓释制剂

Strength

12.5mg （按C₁₉H₂₀FNO₃计）

Drug Type

化学药品

Registration Date

April 30, 2024

Company Information

Applicant Company

Company Name山东京卫制药有限公司

Company Address

山东省泰安市高新技术产业开发区配天门大街西首

Manufacturing Company

Company Name山东京卫制药有限公司

Company Address

山东省泰安高新技术产业开发区配天门大街西首

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy